Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Parsons

Showing results (801-810 of 821) with videos related to

Pageof 83
Sort By:
International Journal of Cancer|May 18, 2010
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialMarkus M Heiss, Pawel Murawa, Piotr Koralewski, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Environmental and Molecular Mutagenesis|June 3, 2024
Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)Barbara L Parsons, Marc A Beal, Kerry L Dearfield, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancerJagath R Junutula, Kelly M Flagella, Richard A Graham, et al.
Cancer Research|November 18, 2008
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugateGail D Lewis Phillips, Guangmin Li, Debra L Dugger, et al.
Mutation Research. Reviews in Mutation Research|August 29, 2023
Error-corrected next generation sequencing - Promises and challenges for genotoxicity and cancer risk assessmentFrancesco Marchetti, Renato Cardoso, Connie L Chen, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 20, 2013
Tragedy into drama: an american history of tourniquet use in the current warJohn F Kragh, Thomas J Walters, Ted Westmoreland, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 8, 2001
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)J Mazziotta, A Toga, A Evans, et al.
Environmental and Molecular Mutagenesis|June 30, 2025
Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex SequencingShaofei Zhang, Barbara L Parsons, Devon Fitzgerald, et al.
Pageof 83

Showing results (801-810 of 821) with videos related to

Sort By:
Pageof 83
International Journal of Cancer|May 18, 2010
The trifunctional antibody catumaxomab for the treatment of malignant ascites due to epithelial cancer: Results of a prospective randomized phase II/III trialMarkus M Heiss, Pawel Murawa, Piotr Koralewski, et al.
Molecular Cancer Therapeutics|February 14, 2016
3-Dimensional Patient-Derived Lung Cancer Assays Reveal Resistance to Standards-of-Care Promoted by Stromal Cells but Sensitivity to Histone Deacetylase InhibitorsDavid Onion, Richard H Argent, Alexander M Reece-Smith, et al.
Environmental and Molecular Mutagenesis|June 3, 2024
Severity of effect considerations regarding the use of mutation as a toxicological endpoint for risk assessment: A report from the 8th International Workshop on Genotoxicity Testing (IWGT)Barbara L Parsons, Marc A Beal, Kerry L Dearfield, et al.
Gut|October 30, 2013
British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagusRebecca C Fitzgerald, Massimiliano di Pietro, Krish Ragunath, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2010
Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancerJagath R Junutula, Kelly M Flagella, Richard A Graham, et al.
Cancer Research|November 18, 2008
Targeting HER2-positive breast cancer with trastuzumab-DM1, an antibody-cytotoxic drug conjugateGail D Lewis Phillips, Guangmin Li, Debra L Dugger, et al.
Mutation Research. Reviews in Mutation Research|August 29, 2023
Error-corrected next generation sequencing - Promises and challenges for genotoxicity and cancer risk assessmentFrancesco Marchetti, Renato Cardoso, Connie L Chen, et al.
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals|September 20, 2013
Tragedy into drama: an american history of tourniquet use in the current warJohn F Kragh, Thomas J Walters, Ted Westmoreland, et al.
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 8, 2001
A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM)J Mazziotta, A Toga, A Evans, et al.
Environmental and Molecular Mutagenesis|June 30, 2025
Transferability, Reproducibility and Sensitivity of Mutation Quantification by Duplex SequencingShaofei Zhang, Barbara L Parsons, Devon Fitzgerald, et al.
Pageof 83